Envoy Medical (Envoy Medical) Net Margin % : -5,137.89% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Envoy Medical's Net Income for the three months ended in Dec. 2023 was $-4.88 Mil. Envoy Medical's Revenue for the three months ended in Dec. 2023 was $0.10 Mil. Therefore, Envoy Medical's net margin for the quarter that ended in Dec. 2023 was -5,137.89%.

The historical rank and industry rank for Envoy Medical's Net Margin % or its related term are showing as below:

COCH' s Net Margin % Range Over the Past 10 Years
Min: -9464.56 Med: -6718.57 Max: -2798.39
Current: -6959.66

COCH's Net Margin % is ranked worse than
97.54% of 814 companies
in the Medical Devices & Instruments industry
Industry Median: -0.41 vs COCH: -6959.66

Envoy Medical Net Margin % Historical Data

The historical data trend for Envoy Medical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Net Margin % Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

Net Margin %

-2,798.39

-6,718.57

-9,464.56

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial			-2,349.12	-57,385.00	-21,025.40	1,953.75	-5,137.89

Competitive Comparison of Envoy Medical's Net Margin %

For the Medical Devices subindustry, Envoy Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envoy Medical's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Envoy Medical's Net Margin % falls into.

Envoy Medical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Envoy Medical's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-29.908	/	0.316
	=	-9,464.56 %

Envoy Medical's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-4.881	/	0.095
	=	-5,137.89 %

Envoy Medical (NAS:COCH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Envoy Medical Net Margin % Related Terms

Thank you for viewing the detailed overview of Envoy Medical's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.